Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma

Polycomb-group (PcG) proteins, such as BMI-1 and EZH2, form multimeric gene -repressing complexes involved in axial patterning, hematopoiesis, and cell cycle regulation. In addition, BMI-1 is involved in experimental lymphomag enesis, Little is known about its role in human lymphomagenesis, Here, BMI- 1 and EZH2 expression patterns are analyzed in a variety of B-cell non-Hodg kin lymphomas (B-NHLs), including small lymphocytic lymphoma, follicular ly mphoma, large B-cell lymphoma, mantle-cell lymphoma, and Burkitt lymphoma. In contrast to the mutually exclusive pattern of BMI-1 and EZH2 in reactive follicles, the neoplastic cells in B-NHLs of intermediate- and high-grade malignancy showed strong coexpression of BMI-1 and EZH2. This pattern overl apped with the expression of Mib-1/Ki-67, a marker for proliferation, Neopl astic cells in B-NHL of low-grade malignancy were either BMI-1-(low)/EZH2() (neoplastic centroblasts) or BMI-1(low)EZH2(-) (neoplastic centrocytes). These observations show that low-, intermediate-, and high grade B-NHLs are associated with increased coexpression of the BMI-1 and EZH2 PcG proteins, whose normal expression pattern is mutually exclusive. This expression pat tern is probably caused by a failure to down-regulate BMI-1 in dividing neo plastic cells, because BMI-1 expression is absent from normal dividing B ce lls. These observations are in agreement with findings in studies of BmI-1 transgenic mice. The extent of BMI-1/ EZH2 coexpression correlated with cli nical grade and the presence of Mib-1/Ki-67 expression, suggesting that the irregular expression of BMI-1 and EZH2 is an early event in the formation of B-NHL. This points to a role for abnormal PcG expression in human lympho magenesis. (C) 2001 by The American Society of Hematology.